ClinicalTrials.Veeva

Menu

Effects of Cardiorespiratory Rehabilitation on the Right Ventricle in Pulmonary Hypertension (Rehab-HTP)

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

Pulmonary Hypertension

Treatments

Other: Stress echocardiography

Study type

Interventional

Funder types

Other

Identifiers

NCT03404492
17-PP-09

Details and patient eligibility

About

Clinical improvement has been demonstrated after cardiorespiratory rehabilitation in patients with pulmonary hypertension. Rehabilitation is therefore now part of the recommendations for good practice. However, no data is available to elucidate the mechanism of this improvement: an improvement in myocardial reserve or an improvement in peripheral muscular capacity? The main objective of this study is to evaluate the difference in right ventricular contractile reserve before and after cardiorespiratory rehabilitation during stress ultrasound in pulmonary hypertension in 10 patients with pulmonary hypertension.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Major patients
  • Proven pulmonary hypertension: PAPm ≥ 25mmHg, known PH
  • Group 1,3,4 or 5 of the pulmonary hypertension classification
  • Clinical stability > 1 month clinically determined by clinician
  • NYHA II or III class
  • Signature of informed consent form following appropriate information
  • Patient affiliated to the Social Security System

Exclusion criteria

  • Associated left heart disease
  • Complex congenital heart disease
  • Acoustic window which does not allow the echocardiography to be performed correctly
  • Permanent cardiac arrhythmia
  • NYHA IV class and NYHA I class
  • Inability to perform at least a minimal effort on an ergometer
  • Unstabilized acute coronary syndrome
  • Compensatory heart failure
  • Disturbances of ventricular rhythm veins, may not be narrowed.
  • Prevalence of high-risk embolic intracardiac thrombus
  • Prevalence of high-risk embolic intracardiac thrombus
  • Preference of a medium to high abundance peericard-like thinning.
  • Venous thromboembolic venous thromboembolic disease (> 3 months)
  • Left ventricular ejector obstruction (severe and/or symptomatic)
  • Persons under guardianship, under curatorship, protected by law
  • Persons deprived of their liberty
  • Pregnant and parturient women
  • Major not able or unable to express consent
  • Minors
  • Inability to perform cardiac rehabilitation
  • Modynamic instability
  • Follow-up impossible for geographical or psychological reasons
  • Inadequate command of the French language

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Patients with pulmonary hypertension
Other group
Treatment:
Other: Stress echocardiography

Trial contacts and locations

1

Loading...

Central trial contact

Pamela MOCERI, PH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems